Cna Financial Corp Instil Bio, Inc. Transaction History

Cna Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$4.21 - $11.15 $95,516 - $252,971	-22,688 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.37 - $22.5 $13,064 - $19,125	850 Added 3.89%	22,688 $388,000
Q2 2021 Aug 12, 2021	BUY	$15.31 - $24.63 $49,145 - $79,062	3,210 Added 17.23%	21,838 $422,000
Q1 2021 May 14, 2021	BUY	$24.23 - $27.06 $451,356 - $504,073	18,628 New	18,628 $467,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.